Faculty and Staff

Department Chair

Michael Danquah

Michael Danquah, M.S., Ph.D., is a Professor of Pharmaceutical Sciences at Chicago State University College of Health Sciences and Pharmacy. He obtained his Bachelors in Chemical Engineering from Kwame Nkrumah University of Science and Technology, Ghana. Dr. Danquah has a Master’s Degree in Chemical Engineering from the University of Kentucky, and a Ph.D. in Pharmaceutics and Drug Delivery from the University of Tennessee Health Science Center.

Dr. Danquah’s research interests include: (i) Design and synthesis of novel biodegradable polymers for controlled drug and nucleic acid delivery, and (ii) Nano-based combination therapy for treating cancer. His research accomplishments in these areas are documented in several published peer-reviewed journal articles. He is the recipient of the AACR Minority-Serving Institution Faculty Scholar in Cancer Research Award, Founder of the Bevinzey Artificial intelligence-powered learning platform and author/editor of the books “Pharmaceutical Calculations: 1001 questions with answers” and “Emerging Trends in Cell and Gene Therapy”.

Dr. Danquah is an editorial board member of nine scientific journals including Pharmaceutical and Frontiers in Hepatic Drug Delivery. He is a regular reviewer of several journals including Pharmaceutical Research and Advanced Drug Delivery Reviews. He is a member of the American Association of Colleges of Pharmacy (AACP), the American Association of Pharmaceutical Scientists (AAPS), and the Controlled Release Society (CRS).



Hafeez Faridi

Hafeez Faridi, Ph.D., is an Associate Professor of Pharmaceutical Sciences at Chicago State University College of Health Sciences and Pharmacy. He earned his M.Phil and Ph.D. degrees in life sciences from Jawaharlal Nehru University in Delhi, India. Prior to joining CSU, he served as an assistant professor at the department of internal medicine, Rush University Medical Center, Chicago IL. Dr. Faridi completed his postdoctoral training from The University of Miami, Miller School of Medicine, Miami. FL. His postdoctoral work focused on the discovery of novel small molecules targeting integrin CD11b. His research led to the discovery of novel integrin CD11b targeting small molecules with anti-inflammatory properties. He has presented his findings at various international meetings.

His research interests are (1) Screening and characterization of small molecules with anti-inflammatory properties. (2) Understanding the physiological mechanisms in chronic kidney disease and identifying the therapeutic targets. Dr. Faridi has published his research work in well known, peer-reviewed journals, such as Science Signaling, and Journal of Clinical Investigation (JCI). He is involved in multidisciplinary and collaborative research in the area of drug discovery including inflammation, cancer and chronic kidney diseases.

Dr. Faridi is a member of several scientific and professional organizations, including the American Association of Colleges of Pharmacy (AACP) and the American Society of Nephrology (ASN). Dr. Faridialso serves as an active member on various institutional committees including curriculum committee and self-study committee. Dr. Faridi is also an Adjunct Assistant Professor in the Department of Internal Medicine, College of Medicine, Rush University Medical Center. Chicago, IL.

Nadeem Fazal

Nadeem Fazal, M.D, Ph.D. is a Fulbright Scholar. He received his MD from King Edward Medical University, Lahore, Pakistan, and Ph.D. in Immunology/Microbiology from The University of Birmingham, England, United Kingdom. He is a member of the American Association of Immunologists (AAI) and American Society for Microbiology (ASM). He completed his Post-doctoral training, Fellowship and later served as faculty at Stritch School of Medicine Loyola University Chicago, Illinois.

Dr. Fazal began his teaching career at the Department of Microbiology and Immunology, Rawalpindi Medical College, The University of Punjab, Lahore. He also served as faculty at Chicago State University Department of Biological Sciences. Currently, Professor of Biomedical Sciences at Chicago State University College of Health Sciences and Pharmacy he has a vast experience in teaching health sciences in different universities worldwide. His experience includes teaching at The University of Birmingham, United Kingdom, King Edward Medical University, Lahore, Rawalpindi Medical College, Rawalpindi, King Faisal University, Dammam, KSA, Azerbaijan Medical University, Baku, Robert Morris University Illinois, and City Colleges of Chicago. He has received President’s and Young Scientist Award from Societies of General Microbiology (SGM), American Society for Microbiology (ASM) and British Society for Immunology (BSI). He was a recipient of Rowtham Bequest Award from The University of Birmingham, England, United Kingdom. He also received numerous Faculty Excellence Awards in Teaching from President of Chicago State University.

Dr. Fazal’s research interests include investigating mechanisms of cellular immune responses to acute injury/infection and pharmacological agents modulating such host responses. He has more than 116 articles published in peer-reviewed scientific journals. His areas of expertise include Immunology, Microbiology, Cell Biology, and Infectious Diseases. Since joining the College of Pharmacy at Chicago State University, he has mentored more than 50 research students in his laboratory. Students working under his supervision have presented at local and national meetings and have won student awards for best presentations. He is a recognized Mentor at National Research Mentoring Network, USA and Careers Network University of Birmingham, United Kingdom. Dr. Fazal has been a member of numerous scientific and professional organizations, including, The American Physiological Society (APS), The American Society of Human Genetics (ASHG), and The American Association of Colleges of Pharmacy (AACP). He also received the Faculty Excellence Award in Research from President of Chicago State University.

Elmer J. Gentry

Elmer J. Gentry, Ph.D., is an Associate Professor of Pharmaceutical Sciences at Chicago State University College of Health Sciences and Pharmacy. Dr. Gentry received his B.S. from Missouri Western State College (1993 in Chemistry) and M.S. (1996) and Ph.D. (1999) in Medicinal Chemistry from the University of Kansas. He served on the faculty at Midwestern University, College of Pharmacy-Glendale from 1999-2007.

He was named the 2007 Teacher of the Year for both the first and second-year pharmacy classes at the College of Pharmacy-Glendale. Additionally, he has received the Edgar C. Little Outstanding Chemistry Graduate Award from Missouri Western State College, the Pharmacy Graduate Student Honors Symposium Award from the University of Kansas, and an American Foundation for Pharmaceutical Education Pre-doctoral fellowship from 1997-1999. He was honored as the National Advisor of the Year runner-up by the Phi Delta Chi pharmacy fraternity.

Dr. Gentry is a member of numerous scientific and professional organizations and has served as the Chair of the Section of Teachers of Chemistry of the American Association of Colleges of Pharmacy. His research interests include synthetic manipulation of antimicrobial agents to modulate potency and spectrum of activity, use of combinatorial chemistry for drug discovery and development, and improving the delivery of science courses for professional and pre-professional students.

Mohammad Newaz

Mohammad Newaz MD, Ph.D., FAHA is Professor of Physiology and Pharmacology at Chicago State University College of Health Sciences and Pharmacy. He is the former Department Chair of Pharmaceutical Sciences. Before joining CSU Dr. Newaz was Associate Professor / Senior Scientist and Head of Hypertension Unit in the Center for Cardiovascular Diseases, Texas Southern University, Houston, Texas. Dr. Newaz received his MD from the University of Chittagong, Bangladesh (1992) and Ph.D. from the National University of Malaysia (1998). He has held faculty positions at the University of Science and Technology Chittagong, Bangladesh, National University of Malaysia and International Islamic University Malaysia before joining the Center for Cardiovascular Diseases in 2000. His research focus is primarily on hypertension and vascular physiology using an integrated investigative approach with special emphasis on understanding molecular events contributing to the pathogenesis of hypertension and its complications

Dr. Newaz is a member of many professional societies, including the American Heart Association, the American Physiological Society. He has received numerous honors and awards, including the Young Investigator Award from High Blood Pressure Council of American Heart Association, Young Investigator Award from the renal section of The American Physiological Society, Caroline Tun Suden professional opportunity award from The American Physiological Society, Young Investigator Award from The International Society of Hypertension, FASEB MARC fellowship and Grant-in-Aid from American Heart Association. He has published more than 40 peer-reviewed research paper in high impact journals, book chapters and invited reviews in the field of hypertension and vascular biology. Dr. Newaz presented his research works extensively at conferences locally and internationally and was also an invited speaker at several Universities in the US.

Melany P. Puglisi

Melany P. Puglisi, Ph.D., is a Professor of Pharmaceutical Sciences at Chicago State University College of Health Sciences and Pharmacy. She received her B.A. in chemistry from Southampton College, now part of Long Island University, in 1991. Her graduate studies were carried out at the University of Guam where she received her M.S. in Biology in 1995 and the University of Mississippi, School of Pharmacy where she received her Ph.D. in pharmacognosy. Dr. Puglisi completed her postdoctoral studies at Scripps Institution of Oceanography at the University of California at San Diego and the Smithsonian Museum of Natural History Marine Station in Fort Pierce, FL. Prior to joining CSU, she was a faculty member in the Department of Pharmaceutical Sciences at Lake Erie College of Osteopathic Medicine. In 2008, Dr. Puglisi joined CSU as a founding faculty member in the College of Pharmacy. Dr. Puglisi’s research interests include: 1) Marine natural products drug discovery, 2) Chemical/ecological interactions between marine organisms and microorganisms, and 3) Scholarship of Teaching and Learning as it relates to improved students’ outcomes in the Pharmacy curriculum. She participated in numerous research expeditions in the tropical Atlantic and Pacific including the 2005 NOAA Florida Coast Deep Corals research cruise. Dr. Puglisi has numerous publications in natural products, microbial chemical ecology, and the scholarship of teaching. She developed the website biochemistryrox.com as a supplement to her course. She is also the lead editor of the book Chemical Ecology: The Ecological Impact of Marine Natural Products (CRC press). Dr. Puglisi received multiple Teacher of the Year awards, a Faculty Preceptor of the Year award, the CSU Service Excellence and CSU Research Excellence Awards. 

Dr. Puglisi is a member of the Editorial Board of the Journal of Natural. She served a member of the Executive Committee of the American Society of Pharmacognosy for eight years and continues to serve as the Secretary to the ASP Foundation. She is a member of several scientific organizations including the American Society of Pharmacognosy and America Society of Women in Science.

Md Obayed Raihan, Ph.D., is an Assistant Professor of Pharmaceutical Sciences at Chicago State University College of Health Sciences and Pharmacy. He received his Ph.D. in Neurobiology from the Department of Neurobiology at the University of Science and Technology of China. He completed his Master of Pharmacy (M.Pharm.) and Bachelor of Pharmacy (B.Pharm.) degrees at the Department of Pharmacy, University of Rajshahi, Bangladesh. With a career spanning 14-years in academia, Dr. Raihan held positions at the Department of Pharmacy at the International Islamic University Chittagong, Bangladesh initially as a Lecturer, and later at the Jashore University of Science and Technology, Bangladesh progressing from Lecturer to Assistant Professor and eventually Associate Professor. In 2023, he joined the Department of Pharmaceutical Sciences at the College of Health Sciences and Pharmacy, Chicago State University, USA as an Assistant Professor. Prior to this role, Dr. Raihan served as a Postdoctoral Research Fellow in the Department of Biomedical Sciences at the School of Medicine and Health Sciences and Biomedical Engineering at the School of Electrical Engineering & Computer Science, University of North Dakota, USA.

His research interests encompass fundamental and translational studies in neurodegeneration, neuroprotection, drug repositioning, and computer aided drug design (CADD). Notably, Dr. Raihan began his early career as a Quality Control Pharmacist at Kemiko Pharmaceuticals Limited, Bangladesh. His research endeavors have involved extensive work with cognitive neuroscience using transgenic mouse models of Synucleinopathy (Parkinson’s) and Alzheimer’s diseases, focusing on glial cells characterization, including microglia and astrocytes, for biomarker identification and the development of glia-targeted therapeutics. Dr. Raihan serves as an editorial board member for Aging Communications and The Eurasian Journal of Medicine, and he also contributes as a reviewer to several international journals, including the Journal of Neurochemistry, Journal of Neuroinflammation, Glia, and Advances in Traditional Medicine, Bioscience Report, and F & C Pharmacology. He is member of various professional organizations, including the American Association of College of Pharmacy (AACP), American Association of Pharmaceutical Scientists (AAPS) and the Society for Neuroscience (SfN).




Daniel W. Pietryla

Daniel W. Pietryla is the Research Laboratory Technician Specialist for Chicago State University College of Health Sciences and Pharmacy. Mr. Pietryla received his Bachelors Degree in Biology from The University of Chicago (1983). Mr. Pietryla is the Lab Manager for the Pharmaceutical Sciences Research Facility.

Before joining the College of Pharmacy at CSU in 2012, Mr. Pietryla was a Research Assistant in the Departments of Biochemistry and Orthopedics at Rush University Medical Center in Chicago. In a career in basic research spanning 27 years, Mr. Pietryla has contributed to, as Co-Author, 6 major publications and 29 scientific abstracts on topics ranging from joint inflammation to intervertebral disc degradation and repair. Mr. Pietryla brings diverse technical skills in biochemical, histological, immunological, surgical, and clinical protocols and methodologies to the Pharmaceutical Sciences Research Lab. 

Dalavia Edmon

Dalavia Edmon, Pharm D is the Director of Professional Laboratories and Laboratory Instructor for Pharmaceutical Dosage Forms. Dr. Edmon obtained her Bachelors of Arts Degree in Chemistry at Lake Forest College, in Lake Forest, Illinois and her Doctor of Pharmacy Degree from the University of Illinois at Chicago, College of Pharmacy, in Chicago, Illinois. Dr. Edmon’s research interest include: the effects of health care disparities in the underserved communities, the impact technology has on medication safety, specifically in an outpatient setting, and examining the importance of sterile compounding training in pharmacy school curriculums and medication safety. Dr. Edmon serves on the board of the Chicago Pharmacists Association (CPhA) as the secretary, and is an active member of the Illinois Council of Health System Pharmacists (ICHP) and the American Association of Colleges of Pharmacy.  Dr. Edmon’s pharmacy background is in community pharmacy, long term care, and medication safety.